BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25418955)

  • 1. Interferon regulatory factor 1 marks activated genes and can induce target gene expression in systemic lupus erythematosus.
    Zhang Z; Shi L; Song L; Ephrem E; Petri M; Sullivan KE
    Arthritis Rheumatol; 2015 Mar; 67(3):785-96. PubMed ID: 25418955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon regulatory factor 1 and histone H4 acetylation in systemic lupus erythematosus.
    Leung YT; Shi L; Maurer K; Song L; Zhang Z; Petri M; Sullivan KE
    Epigenetics; 2015; 10(3):191-9. PubMed ID: 25611806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte enhancers are highly altered in systemic lupus erythematosus.
    Shi L; Zhang Z; Song L; Leung YT; Petri MA; Sullivan KE
    Epigenomics; 2015; 7(6):921-35. PubMed ID: 26442457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global H4 acetylation analysis by ChIP-chip in systemic lupus erythematosus monocytes.
    Zhang Z; Song L; Maurer K; Petri MA; Sullivan KE
    Genes Immun; 2010 Mar; 11(2):124-33. PubMed ID: 19710693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Inflammasome Activity in Systemic Lupus Erythematosus Is Mediated via Type I Interferon-Induced Up-Regulation of Interferon Regulatory Factor 1.
    Liu J; Berthier CC; Kahlenberg JM
    Arthritis Rheumatol; 2017 Sep; 69(9):1840-1849. PubMed ID: 28564495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced interferon regulatory factor 3 binding to the interleukin-23p19 promoter correlates with enhanced interleukin-23 expression in systemic lupus erythematosus.
    Smith S; Gabhann JN; Higgs R; Stacey K; Wahren-Herlenius M; Espinosa A; Totaro MG; Sica A; Ball E; Bell A; Johnston J; Browne P; O'Neill L; Kearns G; Jefferies CA
    Arthritis Rheum; 2012 May; 64(5):1601-9. PubMed ID: 22127978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon regulatory factor 5 activation in monocytes of systemic lupus erythematosus patients is triggered by circulating autoantigens independent of type I interferons.
    Stone RC; Feng D; Deng J; Singh S; Yang L; Fitzgerald-Bocarsly P; Eloranta ML; Rönnblom L; Barnes BJ
    Arthritis Rheum; 2012 Mar; 64(3):788-98. PubMed ID: 21968701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin activates IRF1 and leads to altered balance of histone acetylation: Implications for systemic lupus erythematosus.
    Leung YT; Maurer K; Song L; Convissar J; Sullivan KE
    Mod Rheumatol; 2020 May; 30(3):532-543. PubMed ID: 31104557
    [No Abstract]   [Full Text] [Related]  

  • 9. Lupus Susceptibility Region Containing CDKN1B rs34330 Mechanistically Influences Expression and Function of Multiple Target Genes, Also Linked to Proliferation and Apoptosis.
    Singh B; Maiti GP; Zhou X; Fazel-Najafabadi M; Bae SC; Sun C; Terao C; Okada Y; Heng Chua K; Kochi Y; Guthridge JM; Zhang H; Weirauch M; James JA; Harley JB; Varshney GK; Looger LL; Nath SK
    Arthritis Rheumatol; 2021 Dec; 73(12):2303-2313. PubMed ID: 33982894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interleukin-2 signaling pathway regulating molecules in systemic lupus erythematosus].
    Guo Q; Chen XY; Su Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1100-1104. PubMed ID: 27987522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor α regulates tripartite motif-containing protein 21 expression, contributing to dysregulated cytokine production in systemic lupus erythematosus.
    Smith S; Ní Gabhann J; McCarthy E; Coffey B; Mahony R; Byrne JC; Stacey K; Ball E; Bell A; Cunnane G; Doran MF; Molloy ES; Lee RZ; Harvey B; Kearns G; Jefferies CA
    Arthritis Rheumatol; 2014 Jan; 66(1):163-72. PubMed ID: 24449583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone modifications underlie monocyte dysregulation in patients with systemic sclerosis, underlining the treatment potential of epigenetic targeting.
    van der Kroef M; Castellucci M; Mokry M; Cossu M; Garonzi M; Bossini-Castillo LM; Chouri E; Wichers CGK; Beretta L; Trombetta E; Silva-Cardoso S; Vazirpanah N; Carvalheiro T; Angiolilli C; Bekker CPJ; Affandi AJ; Reedquist KA; Bonte-Mineur F; Zirkzee EJM; Bazzoni F; Radstake TRDJ; Rossato M
    Ann Rheum Dis; 2019 Apr; 78(4):529-538. PubMed ID: 30793699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H3K4 tri-methylation breadth at transcription start sites impacts the transcriptome of systemic lupus erythematosus.
    Zhang Z; Shi L; Dawany N; Kelsen J; Petri MA; Sullivan KE
    Clin Epigenetics; 2016; 8():14. PubMed ID: 26839600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibited expression of hematopoietic progenitor kinase 1 associated with loss of jumonji domain containing 3 promoter binding contributes to autoimmunity in systemic lupus erythematosus.
    Zhang Q; Long H; Liao J; Zhao M; Liang G; Wu X; Zhang P; Ding S; Luo S; Lu Q
    J Autoimmun; 2011 Nov; 37(3):180-9. PubMed ID: 22014533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent interferon regulatory factor 1 (IRF1) binding at remote elements without histone modification.
    Abou El Hassan M; Huang K; Xu Z; Yu T; Bremner R
    J Biol Chem; 2018 Jun; 293(26):10353-10362. PubMed ID: 29748386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible role of the JAK/STAT pathways in the regulation of T cell-interferon related genes in systemic lupus erythematosus.
    Kawasaki M; Fujishiro M; Yamaguchi A; Nozawa K; Kaneko H; Takasaki Y; Takamori K; Ogawa H; Sekigawa I
    Lupus; 2011 Oct; 20(12):1231-9. PubMed ID: 21980035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I interferons and the cytokine TNF cooperatively reprogram the macrophage epigenome to promote inflammatory activation.
    Park SH; Kang K; Giannopoulou E; Qiao Y; Kang K; Kim G; Park-Min KH; Ivashkiv LB
    Nat Immunol; 2017 Oct; 18(10):1104-1116. PubMed ID: 28825701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced GATA4 expression in senescent systemic lupus erythematosus monocytes promotes high levels of IFNα production.
    Kuga T; Chiba A; Murayama G; Hosomi K; Nakagawa T; Yahagi Y; Noto D; Kusaoi M; Kawano F; Yamaji K; Tamura N; Miyake S
    Front Immunol; 2024; 15():1320444. PubMed ID: 38605949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Types I and II interferons upregulate the costimulatory CD80 molecule in monocytes via interferon regulatory factor-1.
    Bauvois B; Nguyen J; Tang R; Billard C; Kolb JP
    Biochem Pharmacol; 2009 Sep; 78(5):514-22. PubMed ID: 19433065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An interferon-sensitive response element is involved in constitutive caspase-8 gene expression in neuroblastoma cells.
    De Ambrosis A; Casciano I; Croce M; Pagnan G; Radic L; Banelli B; Di Vinci A; Allemanni G; Tonini GP; Ponzoni M; Romani M; Ferrini S
    Int J Cancer; 2007 Jan; 120(1):39-47. PubMed ID: 17036321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.